1) Yura Y, Tauchi K, Koshiyama M, et al : Parametrial involvement in endometrial carcinomas : Its incidence and correlation with other histological parameters. Gynecol Oncol 63 : 114─119, 1996
2) Sato R, Jobo T, Kuramoto H : Parametrial spread is a prognostic factor in endometrial carcinoma. Eur J Gynaecol Oncol 24 : 241─245, 2003
3) Creutzberg CL, van Putten WL, Koper PC, et al : Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma : multicentre randomised trial. PORTEC Study Group. PostOperative Radiation Therapy in Endometrial Carcinoma. Lancet 355 : 1401─1411, 2000
4) Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al : Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients : the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 22 : 1234─1241, 2004
5) Keys HM, Roberts JA, Brunetto VL, et al : A phase III trial of surgery with or without adjunctive external radiation therapy in intermediate risk endometrial adenocarcinoma : a Gynecologic Oncology Group study. Gynecol Oncol 92 : 744─751, 2004
6) Carey MS, O’Connell GJ, Johanson CR, et al : Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57 : 135─137, 1995
7) 中山裕樹,黒瀬圭輔,佐治晴哉,他 : 日婦腫瘍会誌20 : 416─420,2002
8) Aadlers J, Abeller V, Kolstad P, Onsrud M : Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 56 : 419─427, 1980
9) Nout RA, Smit VT, Putter H, et al : Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk(PORTEC-2): an open-label, non-inferiority, randomized trial. Lancet 375 : 816─823, 2010
10) Horowitz NS : Peters 3rd WA, Smith MR, et al : Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol 99 : 235─240, 2002
11) Alektiar KM, Venkatraman E, Chi DS, et al : Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys 62 : 111─117, 2005
12) Jolly S, Vargas C, Kumar T, et al : Vaginal brachytherapy alone : An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 97 : 887─892, 2005
13) Atahan IL, Ozyar E, Yildiz F, et al : Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery. Int J Gynecol Cancer 18 : 1294─1299, 2008
14) McCloskey SA, Tchabo NE, Malhotra HK, et al : Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol 116 : 404─407, 2010
15) 日本婦人科腫瘍学会(編) : 子宮体がん治療ガイドライン2009年版,金原出版
16) Watanabe Y, Aoki D, Kitagawa R, et al : Status of surgical treatment procedures for endometrial cancer in Japan : results of a Japanease Gynecologic Oncology Group survey. Gynecol Oncol 105 : 325─328, 2007